Since its first approval in 2022, Gilead Sciences’ lenacapavir—a twice-yearly injectable—has come to be a potential game ...

Discover how UCSF is leading the charge in Long COVID research, uncovering key findings that advance our understanding of the condition. UCSF researchers have adapted innovative tools and ...

State Rep. ANGIE NIXON has been a vocal critic of Gov. RON DESANTIS in the Legislature. Now, she’s vying for the Democratic nomination for Senate to go up against Sen. ASHLEY MOODY, the Republican ...

Major donor nations dealt a devastating blow to the right to health for millions of people worldwide when they cut support for the Global Fund to Fight AIDS, Tuberculosis and Malaria.

State officials said the change is being made to prevent a shortfall of more than $120 million in the program for low-income people living with HIV.

Lithium, a widely used treatment for bipolar disorder and other mood disorders, has shown early promise in suppressing HIV, ...

At the end of 2022, the last year for which CDC data was publicly available, there were 135,400 people living with HIV in ...

A new study suggests that micro-doses of THC could help counter many long-term side effects of HIV treatment without causing intoxication. In animal models, low-dose THC reduced inflammation, improved ...

Trump’s dismantling of USAID and deep foreign aid cuts are forcing international NGOs to shrink, localise and seek new ...

Offering non-monetary incentives such as free access to outpatient consultations to frequent blood donors is linked to an increase in donations without compromising blood safety, finds a study from ...

Humanitarian efforts to fight diseases such as HIV, malaria and tuberculosis in some of the world's poorest nations have been ...

This study uses Population-based HIV Impact Assessments survey data to examine factors associated with gender disparities in ...